Michael E Klepser

Michael  E Klepser

Ferris State University

H-index: 49

North America-United States

About Michael E Klepser

Michael E Klepser, With an exceptional h-index of 49 and a recent h-index of 23 (since 2020), a distinguished researcher at Ferris State University, specializes in the field of Infectious Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis

Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Implementation of a pharmacy-based blood lead testing program: A retrospective analysis

Community pharmacist‐provided test and treat programs for acute infectious conditions

Time and motion study of hepatitis C virus point-of-care testing in community pharmacies

Molecular point-of-care testing in the community pharmacy setting: current status and future prospects

Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement

Michael E Klepser Information

University

Position

___

Citations(all)

6988

Citations(since 2020)

1862

Cited By

5929

hIndex(all)

49

hIndex(since 2020)

23

i10Index(all)

109

i10Index(since 2020)

55

Email

University Profile Page

Ferris State University

Google Scholar

View Google Scholar Profile

Michael E Klepser Skills & Research Interests

Infectious Diseases

Top articles of Michael E Klepser

Title

Journal

Author(s)

Publication Date

Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis

Annals of Pharmacotherapy

Alex J Adams

Michael E Klepser

2024/4

Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead

Research in Social and Administrative Pharmacy

Ben Zalupski

Zeina Elroumi

Donald G Klepser

Nicklas S Klepser

Alex J Adams

...

2024/3/15

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Research in Social and Administrative Pharmacy

Teresa A Beam

Donald G Klepser

Michael E Klepser

David R Bright

Nicklas Klepser

...

2023/10/1

Implementation of a pharmacy-based blood lead testing program: A retrospective analysis

Journal of the American Pharmacists Association

Brittany McMahon

Madeline Fouts

Donald Klepser

Michael Klepser

2023/9/1

Community pharmacist‐provided test and treat programs for acute infectious conditions

Journal of the American College of Clinical Pharmacy

Renee R Koski

Nick Klepser

Madelyn Koski

Michael Klepser

Donald Klepser

2023/9

Time and motion study of hepatitis C virus point-of-care testing in community pharmacies

Journal of the American Pharmacists Association

Thomas Beuschel

Eric Gootee

Mark Jordan

Taylor Sikkenga

Donald G Klepser

...

2023/1/1

Molecular point-of-care testing in the community pharmacy setting: current status and future prospects

Michael Klepser

Renee R Koski

2022/10/3

Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement

Implementation Science Communications

Kenneth C Hohmeier

Kimberly McKeirnan

Julie Akers

Michael Klepser

Stephanie A Klepser

...

2022/7/16

Peer Reviewed: Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program

Preventing Chronic Disease

Donald G Klepser

Michael E Klepser

Philip J Peters

Karen W Hoover

Paul J Weidle

2022

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals

Antimicrobial Stewardship & Healthcare Epidemiology

Monica V Mahoney

Hita Bhagat

Robbie Christian

Carlos Del Rio

Kenneth C Hohmeier

...

2022/1

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities

Research in Social and Administrative Pharmacy

Nicklas S Klepser

Donald G Klepser

Jennifer L Adams

Alex J Adams

Michael E Klepser

2021/9/1

The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing

Donald G Klepser

Nicklas S Klepser

Jennifer L Adams

Alex J Adams

Michael E Klepser

2021/8/3

Pharmacy-based point-of-care testing: how a “standard of care” approach can facilitate sustainability

Innovations in Pharmacy

Alex J Adams

Donald G Klepser

Michael E Klepser

Jennifer L Adams

2021

Pharmacist prescriptive authority for acne: an evidence-based approach to policy

Jennifer Athay Adams

Alex J Adams

Michael E Klepser

2021

A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information

Casey M Kepczynski

Jaelin A Genigeski

Renee R Koski

Allison C Bernknopf

Alison M Konieczny

...

2021/11/1

Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: a diagnostic accuracy study

Exploratory Research in Clinical and Social Pharmacy

Casey M Kepczynski

Jaelin A Genigeski

Daniel P de Regnier

Emmanuel D Jadhav

Minji Sohn

...

2021/9/1

Assessment of antibiotic use and concordance with practice guidelines within 3 diverse ambulatory clinic systems

Journal of the American Pharmacists Association

Minji Sohn

Daniel Chung

Erik Winterholler

Bryant Hammershaimb

Cameron Leist

...

2020/11/1

Design of a disaster preparedness escape room for first and second-year pharmacy students

Currents in pharmacy teaching and learning

S Eric Nybo

Stephanie A Klepser

Michael Klepser

2020/6/1

Pharmacy-based infectious disease management programs incorporating CLIA-waived point-of-care tests

SR Herbin

DG Klepser

ME Klepser

2020/4/23

Pharmacy-based assessment and management of herpes labialis (cold sores) with antiviral therapy

INNOVATIONS in pharmacy

Alex J Adams

Michael E Klepser

2020

See List of Professors in Michael E Klepser University(Ferris State University)